MedPath

ZOLPIDEM TARTRATE

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZOLPIDEM TARTRATE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE TABLETS Zolpidem tartrate tablets, USP -CIV Initial U.S. Approval: 1992

Approved
Approval ID

8a0a454e-b18e-4d89-bf16-943c4c968fe2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 3, 2011

Manufacturers
FDA

RedPharm Drug Inc.

DUNS: 008039641

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

zolpidem tartrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67296-0619
Application NumberANDA077903
Product Classification
M
Marketing Category
C73584
G
Generic Name
zolpidem tartrate
Product Specifications
Route of AdministrationORAL
Effective DateJune 3, 2011
FDA Product Classification

INGREDIENTS (9)

FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
ZOLPIDEM TARTRATEActive
Quantity: 5 mg in 1 1
Code: WY6W63843K
Classification: ACTIB
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ZOLPIDEM TARTRATE - FDA Drug Approval Details